Alternaria toxins as casein kinase 2 inhibitors and possible consequences for estrogenicity: a hybrid in silico/in vitro study
Open Access
- 22 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archives of Toxicology
- Vol. 94 (6), 2225-2237
- https://doi.org/10.1007/s00204-020-02746-x
Abstract
Emerging mycotoxins produced by Alternaria spp. were previously reported to exert cytotoxic, genotoxic, but also estrogenic effects in human cells. The involved mechanisms are very complex and not fully elucidated yet. Thus, we followed an in silico target fishing approach to extend knowledge on the possible biological targets underlying the activity of alternariol, taken as the signature compound of Alternaria toxins. Combining ligand-based screening and structure-based modeling, the ubiquitous casein kinase 2 (CK2) was identified as a potential target for the compound. This result was validated in a cell-free in vitro CK2 activity assay, where alternariol inhibited CK2 with an IC50 of 707 nM. As CK2 was recently discussed to influence estrogen receptor (ER) transcription and DNA-binding affinity, we assessed a potential impact on the mRNA levels of ER alpha or ER beta by qRT-PCR and on nuclear localization of the receptors by confocal microscopy, using estrogen-sensitive Ishikawa cells as a model. While AOH did not affect the transcription of ER alpha or ER beta, an increase in nuclear localization of ER alpha after incubation with 10 mu M AOH was observed. However, this effect might be due to ER binding affinity and therefore estrogenicity of AOH. Furthermore, in silico docking simulation revealed not only AOH, but also a number of other Alternaria toxins as potential inhibitors of CK2, including alternariol monomethyl ether and the perylene quinone derivative altertoxin II (ATX-II). These findings were representatively confirmed in vitro for the perylene quinone derivative altertoxin II, which was found to inhibit the kinase with an IC50 of 5.1 mu M. Taken together, we propose CK2 inhibition as an additional mechanism to consider in future studies for alternariol and several other Alternaria toxins.Keywords
This publication has 52 references indexed in Scilit:
- Novel non-ATP competitive small molecules targeting the CK2 α/β interfaceBioorganic & Medicinal Chemistry, 2018
- Delphinidin protects colon carcinoma cells against the genotoxic effects of the mycotoxin altertoxin IIToxicology Letters, 2018
- A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066Bioorganic & Medicinal Chemistry, 2017
- Hazard identification of cis/trans -zearalenone through the looking-glassFood and Chemical Toxicology, 2015
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- In vitro mechanism for downregulation of ER ‐α expression by epigallocatechin gallate in ER +/ PR + human breast cancer cellsMolecular Nutrition & Food Research, 2013
- Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone ϕ, ψ and Side-Chain χ1 and χ2 Dihedral AnglesJournal of Chemical Theory and Computation, 2012
- A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and ApplicationJournal of Chemical Information and Modeling, 2007
- Hydrogen Bonding Interactions of Covalently Bonded Fluorine Atoms: From Crystallographic Data to a New Angular Function in the GRID Force FieldJournal of Medicinal Chemistry, 2004
- The Protein Data BankNucleic Acids Research, 2000